These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 34018314)

  • 21. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare case of severe cholangiopathy following critical illness.
    Patel KV; Zaman S; Chang F; Wilkinson M
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25270153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.
    Bologheanu R; Maleczek M; Laxar D; Kimberger O
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):942-950. PubMed ID: 33909109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.
    Esposito I; Kubisova A; Stiehl A; Kulaksiz H; Schirmacher P
    Virchows Arch; 2008 Oct; 453(4):339-45. PubMed ID: 18769938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients.
    Klein SJ; Bellmann R; Dejaco H; Eschertzhuber S; Fries D; Furtwängler W; Gasteiger L; Hasibeder W; Helbok R; Hochhold C; Hofer S; Kirchmair L; Krismer C; Ladner E; Lehner GF; Mathis S; Mayr A; Mittermayr M; Peer A; Preuß Hernández C; Reitter B; Ströhle M; Swoboda M; Thomé C; Joannidis M
    Wien Klin Wochenschr; 2020 Nov; 132(21-22):653-663. PubMed ID: 33170333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.
    Tampe D; Korsten P; Bremer SCB; Winkler MS; Tampe B
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary sclerosing cholangitis in critically ill patients: current perspectives.
    Gudnason HO; Björnsson ES
    Clin Exp Gastroenterol; 2017; 10():105-111. PubMed ID: 28694703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.
    Ludwig DR; Anderson MA; Itani M; Sharbidre KG; Lalwani N; Paspulati RM
    Abdom Radiol (NY); 2023 Jan; 48(1):151-165. PubMed ID: 35585354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.
    Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER
    Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic.
    Morão B; Revés JB; Nascimento C; Loureiro R; Glória L; Palmela C
    GE Port J Gastroenterol; 2022 Mar; 27(Suppl 2):1-6. PubMed ID: 35528723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary sclerosing cholangitis.
    Ruemmele P; Hofstaedter F; Gelbmann CM
    Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies.
    Bartoli A; Cursaro C; Andreone P
    Curr Opin Gastroenterol; 2022 Mar; 38(2):89-97. PubMed ID: 35098930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary sclerosing cholangitis in cardiac surgical patients: A complication with a dismal prognosis.
    Schade I; Radakovic D; Hoffmann J; Sommer SP; Stefenelli U; Schimmer C; Leyh RG; Aleksic I
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):906-912. PubMed ID: 28554673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study.
    Pouwels S; Ramnarain D; Aupers E; Rutjes-Weurding L; van Oers J
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34210077
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of Critical Care Occupancy and Outcomes of Critically Ill Patients during the 2020 COVID-19 Winter Surge and 2009 H1N1 Influenza Pandemic in Australia.
    Serpa Neto A; Burrell AJC; Bailey M; Broadley T; Cooper DJ; French CJ; Pilcher D; Plummer MP; Trapani T; Webb SA; Bellomo R; Udy A
    Ann Am Thorac Soc; 2021 Aug; 18(8):1380-1389. PubMed ID: 33356988
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.
    Martins P; Verdelho Machado M
    GE Port J Gastroenterol; 2020 Feb; 27(2):103-114. PubMed ID: 32266307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.